SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AutoImmune-AIMM
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nanocap who wrote (286)5/20/1999 8:43:00 AM
From: Zeev Hed  Read Replies (1) of 298
 
nano, yes it seems that the stock is "painting a base" pattern, but I also think that it will go back to $2 sometime before the end of July, and then, I may reenter. Many small caps are either starting upmoves or basing out of long term declines. AIMM is one with better financials than most in this respect. Still a quite full kitty. My only problem is with the validity of the oral route for therapeutic agents for autoimmune diseases. The proofs are not very convincing, unless you have some new data.

Zeev
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News